Literature DB >> 11692272

Na+ transport by the neural glutamine transporter ATA1.

A Albers1, A Bröer, C A Wagner, I Setiawan, P A Lang, E U Kranz, F Lang, S Bröer.   

Abstract

Transfer of glutamine between astrocytes and neurons is an essential part of the glutamate-glutamine cycle in the brain. Here we have investigated how the neural glutamine transporter (rATA1/GlnT) works. Rat ATA1 was expressed in Xenopus laevis oocytes and examined using two-electrode voltage-clamp recordings, ion-sensitive microelectrodes and tracer flux experiments. Glutamine transport via rATA1 was electrogenic and caused inward currents that did not reverse at positive holding potentials. Currents were induced by a variety of neutral amino acids in the following relative order Ala>Ser/Gln/Asn/His/Cys/Met >MeAIB/Gly>Thr/Pro/Tyr/Val, where MeAIB is the amino acid analogue N-methylaminoisobutyric acid. The uptake of glutamine and the corresponding currents depended on Na+ and pH. Hill-coefficient and flux studies with 22NaCl indicated a cotransport stoichiometry 1 Na+ per transport cycle. The transporter also showed uncoupled Na+ transport, particularly when alanine was used as the substrate. Although substrate uptake increased strongly with increasing pH, no change of intracellular pH was observed during transport. A decrease of the intracellular pH similarly inhibited glutamine transport via ATA1, suggesting that the pH dependence was an allosteric effect on the transporter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692272     DOI: 10.1007/s004240100663

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  26 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Evidence for allosteric regulation of pH-sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity involving a conserved histidine residue.

Authors:  Fiona E Baird; Jorge J Pinilla-Tenas; William L J Ogilvie; Vadival Ganapathy; Harinder S Hundal; Peter M Taylor
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

Review 3.  The SLC38 family of sodium-amino acid co-transporters.

Authors:  Stefan Bröer
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 5.  An L-Glutamine Transporter Isoform for Neurogenesis Facilitated by L-Theanine.

Authors:  Yukio Yoneda
Journal:  Neurochem Res       Date:  2017-06-09       Impact factor: 3.996

6.  Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus.

Authors:  Keiko Kanamori; Brian D Ross
Journal:  Epilepsy Res       Date:  2013-09-01       Impact factor: 3.045

7.  The C-terminal domain of the neutral amino acid transporter SNAT2 regulates transport activity through voltage-dependent processes.

Authors:  Zhou Zhang; Catherine B Zander; Christof Grewer
Journal:  Biochem J       Date:  2011-03-01       Impact factor: 3.857

8.  SLC38A1 promotes proliferation and migration of human colorectal cancer cells.

Authors:  Fen-Fang Zhou; Wei Xie; Shuang-Qian Chen; Xiao-Kang Wang; Qing Liu; Xue-Kai Pan; Fei Su; Mao-Hui Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

Review 9.  Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family.

Authors:  Bryan Mackenzie; Jeffrey D Erickson
Journal:  Pflugers Arch       Date:  2003-07-04       Impact factor: 3.657

10.  SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.

Authors:  Mohamed Hassanein; Megan D Hoeksema; Masakazu Shiota; Jun Qian; Bradford K Harris; Heidi Chen; Jonathan E Clark; William E Alborn; Rosana Eisenberg; Pierre P Massion
Journal:  Clin Cancer Res       Date:  2012-12-04       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.